The Prevention Gap: Overcoming the Barriers to Adopting Preventive Health Innovation

HPAI costs hundreds of millions per outbreak. PRRS circulates persistently through the most biosecure swine systems in the world. The science to prevent both exists. Yet delivering solutions at a commercial scale is limited by challenges in demonstrating ROI and operational capacity.  

• How the economics of prevention need to be reframed around visible, near-term financial return rather than disease avoidance alone
• How data, diagnostics, and early detection are shifting biosecurity from reactive to preventive, and what tools are genuinely changing producer behavior
• The role of vaccination and emerging biological tools in building more resilient production systems at commercial scale
• What designing prevention systems for real operational conditions, consolidating herds, untrained workforces, and hostile environments, actually requires
• What collaboration across producers, industry, and regulators needs to look like to make progress at scale